<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://finance.naver.com/news/news_list.naver?mode=LSS3D&amp;section_id=101&amp;section_id2=258&amp;section_id3=402</id>
    <title>네이버 금융 ─ 뉴스 ─ 기업 종목분석</title>
    <updated>2021-12-08T06:09:46.692Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://finance.naver.com/news/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[위메이드, '다크에덴' 개발사 위믹스 플랫폼 합류 소식에 9%↑]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004680799&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004680799&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.634Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004680799&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="위메이드, '다크에덴' 개발사 위믹스 플랫폼 합류 소식에 9%↑">위메이드, '다크에덴' 개발사 위믹스 플랫폼 합류 소식에 9%↑</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[“이제 MZ세대가 관리자”···커넥트밸류-대학내일, 교육 프로그램 세미나 개최]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004752473&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004752473&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.634Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004752473&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="“이제 MZ세대가 관리자”···커넥트밸류-대학내일, 교육 프로그램 세미나 개최">“이제 MZ세대가 관리자”···커넥트밸류-대학내일, 교육 프로그램 세미나 개최</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주] "확진자 급증...재택치료 대폭 개선할 것"...원격진료株 급등세]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0003994420&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0003994420&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.634Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0003994420&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="[특징주] &quot;확진자 급증...재택치료 대폭 개선할 것&quot;...원격진료株 급등세">[특징주] "확진자 급증...재택치료 대폭 개선할 것"...원격진료株 급등세</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[한신평 “韓 기업 신용도 회복, 2022년에도 이어질 것”]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004752463&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004752463&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.635Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004752463&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="한신평 “韓 기업 신용도 회복, 2022년에도 이어질 것”">한신평 “韓 기업 신용도 회복, 2022년에도 이어질 것”</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[브이티지엠피, 日 라쿠텐 시트 마스크 1위 수상… 시카 라인 ‘돌풍’ 재확인]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0005012290&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0005012290&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.636Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0005012290&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="브이티지엠피, 日 라쿠텐 시트 마스크 1위 수상… 시카 라인 ‘돌풍’ 재확인">브이티지엠피, 日 라쿠텐 시트 마스크 1위 수상… 시카 라인 ‘돌풍’ 재확인</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[LG화학, 자회사 상장 기대감에 장중 5% 상승]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004680772&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004680772&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.637Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004680772&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="LG화학, 자회사 상장 기대감에 장중 5% 상승">LG화학, 자회사 상장 기대감에 장중 5% 상승</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[군인공제회C&C, 강원도 현역용사 전용 '나라사랑페이' 출시]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004752448&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004752448&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.639Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004752448&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="군인공제회C&amp;C, 강원도 현역용사 전용 '나라사랑페이' 출시">군인공제회C&amp;C, 강원도 현역용사 전용 '나라사랑페이' 출시</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[금호에이치티, 두올물산 핵심 ‘오레고보맙’ 발표 “난소암 치료 필수 약제”]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004752444&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004752444&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.641Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004752444&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="금호에이치티, 두올물산 핵심 ‘오레고보맙’ 발표 “난소암 치료 필수 약제”">금호에이치티, 두올물산 핵심 ‘오레고보맙’ 발표 “난소암 치료 필수 약제”</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[삼성바이오로직스, 외인 매수세에 4% 강세]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004680765&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004680765&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1"/>
        <updated>2021-12-08T06:07:44.644Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004680765&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1" title="삼성바이오로직스, 외인 매수세에 4% 강세">삼성바이오로직스, 외인 매수세에 4% 강세</a>]]></content>
    </entry>
</feed>